サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1325319

ラクトフェリンの世界市場-2023年～2030年

Global Lactoferrin Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 102 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
ラクトフェリンの世界市場-2023年～2030年
出版日: 2023年08月04日
発行: DataM Intelligence
ページ情報: 英文 102 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

世界のラクトフェリン市場は、2022年に3億6,230万米ドルに達し、2030年には6億4,130万米ドルに達するという有利な成長が予測されています。予測期間2023-2030年のCAGRは7.4%です。

特定の健康効果を持つ栄養補助食品や機能性食品に対する消費者の関心が高まっています。ラクトフェリンは免疫強化、腸内健康促進、抗酸化作用があるため、機能性食品やサプリメント製品に使用されています。顧客は、全体的な健康と幸福を高めるための自然で実用的な方法を探しているため、ラクトフェリンを強化した商品をより頻繁に使用すると予想されます。

例えば、2023年3月17日、FrieslandCampina Ingredients社はオランダのVeghelに新しいラクトフェリン生産工場を建設しました。この施設により、同社の総生産能力は年間20トンから80トンに増強されます。

市場力学

乳幼児人口の増加がラクトフェリン市場の成長を牽引

世界の出生率は多くの国で上昇しており、その結果新生児人口が増加しています。出生率は、人口の拡大、ヘルスケア施設の増加、社会経済力学の変化の結果として上昇しています。国連によれば、毎日38万,5000人の新生児が誕生しています。これは毎年、1億4,000万米ドル以上に相当します。より多くの赤ちゃんが生まれるにつれて、特にラクトフェリンを含む乳児用栄養製品の必要性が高まっています。

母乳育児は赤ちゃんにとって最も健康的な栄養源と考えられていますが、特に都市部では、母乳育児からミルク育児への移行が著しいです。この傾向には、働く母親の増加、ライフスタイルの変化、文化的影響など、さまざまな要因が考えられます。その結果、より多くの赤ちゃんが粉ミルク育児に頼るようになり、粉ミルクの選択肢、特にラクトフェリン強化粉ミルクの必要性が高まっています。

ラクトフェリンの健康効果に対する認識の向上が、ラクトフェリン市場の成長を促進

ラクトフェリンは免疫機能を高める可能性が認められています。ラクトフェリンは、リンパ球やナチュラルキラー細胞のような免疫細胞の産生と活性をサポートすることにより、免疫系に好影響を与えることが分かっています。さらに、ラクトフェリンの鉄と結合する能力は、細菌やウイルスの増殖を抑制し、抗菌作用を示します。免疫の健康に対する関心が高まる中、ラクトフェリンは免疫をサポートするサプリメントや機能性食品の貴重な成分として認識されつつあります。

ラクトフェリンは健康な腸の維持に一役買っています。ビフィズス菌や乳酸菌のような有益な細菌の増殖を促進する一方、有害な細菌の増殖を抑制することで、腸内細菌叢の調整を助けます。ラクトフェリンは抗酸化活性を示し、酸化ストレスと闘い、炎症に関連する慢性疾患のリスクを軽減するのに役立ちます。人々が様々な健康状態における炎症の役割をより意識するようになるにつれ、ラクトフェリンの抗炎症作用は市場の成長に寄与しています。

規制と知的財産の問題がラクトフェリン市場の成長を妨げる可能性

規制当局は、ラクトフェリンを含む食品や医薬品に厳しい安全基準や品質基準を設けています。これらの基準を遵守するためには、多くの場合、厳格な試験、トレーサビリティ、品質管理措置が必要となります。これらの基準を満たすには、特に必要な資源や専門知識を持たない小規模生産者にとっては、費用と時間がかかる場合があります。

特許と知的財産権は、ラクトフェリン市場において重要な役割を果たしています。知的財産の保護は、ラクトフェリンベースの製品の研究開発に投資するメーカーにとって不可欠です。しかし、複雑な知的財産権をうまく利用することは困難であり、特許紛争は技術革新と市場の成長を妨げる可能性があります。

COVID-19影響分析

COVID-19分析には、COVID前シナリオ、COVIDシナリオ、COVID後シナリオに加え、価格動向（COVID前シナリオと比較したパンデミック中およびパンデミック後の価格変動を含む）、需給スペクトラム（取引制限、封鎖、およびその後の問題による需給の変化）、政府の取り組み（政府機関による市場、セクター、産業を活性化するための取り組み）、メーカーの戦略的取り組み（COVID問題を緩和するためにメーカーが行ったことをここで取り上げる）が含まれます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 乳幼児人口の増加
      • ラクトフェリンの健康効果に対する認識の高まり
    • 抑制要因
      • 規制と知的財産の問題
    • 機会
      • 機能性成分への需要の高まり
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 COVID-19分析

第7章 供給源別

  • 牛乳
  • 遺伝子組み換え米
  • 豚乳
  • ヒト乳
  • マウス乳
  • その他

第8章 用途別

  • 免疫健康
  • 口腔衛生
  • 腸の健康
  • スキンケア
  • その他

第9章 最終用途別

  • 機能性食品・飲料
  • 栄養補助食品
  • 乳児用調製粉乳
  • 化粧品
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • MILEI GmbH
    • 企業概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な動向
  • Farbest Brands
  • Synlait Ltd.
  • Glanbia Plc.
  • Bega Bionutrients
  • Saputa Dairy Australia Pty Ltd.
  • Forterra Co-Operative Group
  • Armor Proteins
  • Hilmar Cheese Company, Inc.
  • Conagen, Inc.

第13章 付録

目次
Product Code: FB3711

Market Overview

Global Lactoferrin Market reached US$ 362.3 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 641.3 million by 2030. The market is growing at a CAGR of 7.4% during the forecast period 2023-2030.

Consumer interest in dietary supplements and functional foods with specific health benefits is rising. Because of its immune-boosting, gut-health-promoting, and antioxidant properties, lactoferrin is used in functional food and supplement products. Customers are anticipated to use lactoferrin-enriched goods more frequently as they look for natural and practical ways to enhance their overall health and well-being.

For instance, On March 17, 2023, FrieslandCampina Ingredients built a new lactoferrin production plant in Veghel, Netherlands, to assist fulfill rising worldwide demand in the infant and adult nutrition industries. The facility boosts the company's total capacity from 20 to 80 metric tonnes per year.

Market Dynamics

The Rising Infant Population is Driving the Market Growth of Lactoferrin

The global birth rate has been increasing in many countries, resulting to an increase in the newborn population. Birth rates are rising as a result of population expansion, increased healthcare facilities, and altering socioeconomic dynamics. Every day, 385,000 newborns are born, according to the United Nations. Every year, this amounts to more than 140 million dollars. As more babies are born, there is an increased need for baby feeding products, particularly those containing lactoferrin.

While breastfeeding is thought to be the healthiest source of nutrition for babies, there is a significant shift away from breastfeeding and towards formula feeding, particularly in cities. This tendency may be attributed to a number of factors such as an increase in the number of working mothers, lifestyle changes, and cultural influences. As a result, as more babies rely on formula feeding, the need for baby formula options, particularly lactoferrin-enriched formula, grows.

Increased Awareness of Lactoferrin's Health Benefits is Driving Lactoferrin Market Growth

Lactoferrin is recognized for its potential in enhancing immune function. It has been found to have a positive impact on the immune system by supporting the production and activity of immune cells like lymphocytes and natural killer cells. Additionally, lactoferrin's ability to bind to iron inhibits the growth of bacteria and viruses, displaying antimicrobial properties. With growing concerns over immune health, lactoferrin is being recognized as a valuable ingredient for immune-supporting supplements and functional foods.

Lactoferrin plays a role in maintaining a healthy gut. It helps regulate the gut microbiota by promoting the growth of beneficial bacteria like bifidobacteria and lactobacilli while inhibiting the growth of harmful bacteria. Lactoferrin exhibits antioxidant activity, which helps combat oxidative stress and reduce the risk of chronic diseases associated with inflammation. As people become more conscious of the role of inflammation in various health conditions, lactoferrin's anti-inflammatory benefits contribute to its market growth.

Regulatory and Intellectual Property Issues can Hamper the Growth of the Lactoferrin Market

Regulatory authorities set stringent safety and quality standards for food and pharmaceutical products containing lactoferrin. Compliance with these standards often requires rigorous testing, traceability, and quality control measures. Meeting these standards can be costly and time-consuming, especially for small-scale producers who may lack the necessary resources and expertise.

Patents and intellectual property rights play a crucial role in the lactoferrin market. The protection of intellectual property is essential for manufacturers investing in the research and development of lactoferrin-based products. However, navigating the complexities of intellectual property rights can be challenging, and patent disputes can impede innovation and market growth.

COVID-19 Impact Analysis

The COVID-19 Analysis includes Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it to pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown, and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).

Segment Analysis

The global lactoferrin market is segmented based on source, application, end-use, and region.

Abundance of 2'-Fucosyllactose (2'FL) in Human Milk

In 2022, based on the source, bovine lactoferrin held the highest share of the lactoferrin market. Bovine milk is a readily available source of lactoferrin. The dairy industry produces a significant amount of bovine milk, allowing for a consistent and ample supply of bovine lactoferrin. In August 2022, TurtleTree, a biotech company, declared its production of LF + , the world's first sustainable bovine lactoferrin created using precision fermentation technology.

Bovine lactoferrin shares structural and functional similarities with human lactoferrin, making it a suitable substitute in various applications. It exhibits similar immune-enhancing and antimicrobial properties, which are desirable characteristics in products that incorporate lactoferrin. These features encourage producers to supply fresh bovine lactoferrin products, which has boosted market share.

Geographical Analysis

Growing Health Consciousness in North America Regions

In 2022, the North American region had a significant share of the lactoferrin market. The region's healthcare infrastructure possesses advanced medical facilities, research institutes, and pharmaceutical companies, establishing favorable conditions for the progress, manufacturing, and dissemination of products incorporating lactoferrin.

The North American market has witnessed a growing interest in functional foods, dietary supplements, and nutraceuticals. For instance, according to the Centers for Disease Control and Prevention, in 2021, data from the National Health and Nutrition Examination Survey, showed that 57.6%of the US adults of age 20 and over, used dietary supplements. Consumers in this region are increasingly seeking products that offer health benefits beyond basic nutrition. Lactoferrin, with its potential immune-enhancing and gut health properties, aligns well with this trend, driving its demand in the market.

Competitive Landscape

The major global players include MILEI GmbH, Farbest Brands, Synlait Ltd., Glanbia Plc., Bega Bionutrients, Saputa Dairy Australia Pty Ltd., Forterra Co-Operative Group, Armor Proteins, Hilmar Cheese Company, Inc., Conagen, Inc.

Why Purchase the Report?

  • To visualize the global lactoferrin market segmentation based on source, application, end-use, and region understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of Lactoferrin market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The Global Lactoferrin Market Report Would Provide Approximately 61 Tables, 64 Figures, and 102 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Source
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-Use
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Rising Infant Population
      • 4.1.1.2. Increased Awareness of Lactoferrin's Health Benefits
    • 4.1.2. Restraints
      • 4.1.1.2. Regulatory and Intellectual Property Issues
    • 4.1.3. Opportunity
      • 4.1.2.1. Rising Demand for Functional Ingredients
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Source

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 7.1.2. Market Attractiveness Index, By Source
  • 7.2. Bovine Milk *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Engineered Rice
  • 7.4. Porcine Milk
  • 7.5. Human Milk
  • 7.6. Murine Milk
  • 7.7. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Immune Health*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Oral Hygiene
  • 8.4. Gut Health
  • 8.5. Skin Care
  • 8.6. Others

9. By End-Use

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Use
    • 9.1.2. Market Attractiveness Index, By End-Use
  • 9.2. Functional Foods & Drinks*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Dietary Supplements
  • 9.4. Infant Formula
  • 9.5. Cosmetics
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Use
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Use
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Use
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Use
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Use

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. MILEI GmbH*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Farbest Brands
  • 12.3. Synlait Ltd.
  • 12.4. Glanbia Plc.
  • 12.5. Bega Bionutrients
  • 12.6. Saputa Dairy Australia Pty Ltd.
  • 12.7. Forterra Co-Operative Group
  • 12.8. Armor Proteins
  • 12.9. Hilmar Cheese Company, Inc.
  • 12.10. Conagen, Inc.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us